NLRP3 and neoplasm: Interestingly, Huber et al. (42) demonstrated that IL-18 induced by NLRP3 causes the downregulation of the soluble IL-22 receptor, IL-22-binding protein (IL-22BP), leading to an increase in the ratio of IL-22/IL-22BP, which at later stages promotes tumor development (42).